Joel Greenblatt acquired 10.4 Thousand Veracyte shares worth $219 Thousand. That's 0.00% of their equity portfolio (1227th largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares five more times and sold shares on eight occasions. The investor's estimated purchase price is $240 Thousand, resulting in a loss of 8.6%.